$13.940
-0.361 (-2.59%)At close
IMMX News
IMMX Events
Nasdaq Closes Near Flat as Market Eyes Megacap Earnings
The major averages closed lower, with the Nasdaq closing near flat, as stocks looked to rebound from last week's technology-led selloff. Attention is turning to a week of megacap earnings that could determine whether the AI-driven rally regains momentum. However, gains remain restrained by escalating geopolitical tensions in the Middle East.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Domino's Pizzareported, with U.S. same store sales growing 0.1% but international same store sales falling 0.1%Tempus AIPersonalisfor $16.25 per shareAMC Entertainmentreported better-than-expectedBrookfieldand Canada Pension Plan Investment BoardLXP Industrial Trustin a $5.2B all-cash transactionAlibaba'sAliExpress has been fined EUR550M by the EU for2. WALL STREET CALLS:Phillip SecuritiesNetflixto Buy from AccumulateGoldman SachsTravelersto SellCLSAcoverage of Microsoftwith an Outperform rating and $535 price targetBarclaysLumentumto OverweightPenguin Solutionsto Underweight at Barclays3. AROUND THE WEB:U.S. District Judge Araceli Martinez-Olguin ordered Paramount Skydanceand Warner Bros. Discoveryto hold off on consummating their deal to combine for 14 days after California and 11 other states sued to block the merger, Bloomberg reportsGoogleis developing a new AI chip that integrates Gemini model architecture directly into hardware, aiming to improve efficiency and reduce the cost of serving AI models at scale, The Information reportsHoneywellCEO Vimal Kapur said plans to reshape the company were already underway when activist investor Elliott Management took a stake and pushed for a breakup in 2024, Bloomberg saysAerCapis in discussions to buy Boeing787 Dreamliner aircraft, with the leasing company considering as many as 15 of the 787 widebodies, Bloomberg saysSamsunghas cut roles at its U.S. display, phone, and consumer electronics operations at its New Jersey and Texas offices, Reuters reports4. MOVERS:Irenhigher after raising its AI Cloudto over $4B from $3.7BHut 8increases after announcingArcher Aviationgains after announcing its jointly-developed autonomousImmix Biopharmalower after announcing theEnphase Energyfalls after TD Cowenon the stock5. EARNINGS/GUIDANCE:Dynex Capital, with EPS beating consensusZurn Elkay WaterCEO Todd Adams said the company sees Q2 resultsNomad FoodsreportedPeoples Bancorp, with EPS higher year-over-yearKnightscopereported, with revenue higher year-over-yearINDEXES:The Dow fell 307.16, or 0.59%, to 51,839.26, the Nasdaq lost 12.17, or 0.048%, to 25,508.07, and the S&P 500 declined 14.41, or 0.19%, to 7,443.28.
Tech Stocks Rebound as Market Eyes Megacap Earnings
The major averages were mixed near noon as stocks look to rebound from last week's technology-led selloff. Attention is turning to a week of megacap earnings that could determine whether the AI-driven rally regains momentum. However, gains remain restrained by escalating geopolitical tensions in the Middle East.This week's earnings calendar is headlined by Alphabet, Tesla, Intel and IBM, with investors closely watching whether continued heavy spending on artificial intelligence infrastructure is translating into stronger financial results. The reports come after semiconductor stocks suffered a sharp reversal last week, pushing the Philadelphia Semiconductor Index more than 20% below its June high and into bear market territory.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Domino's Pizzareported, with U.S. same store sales growing 0.1% but international same store sales falling 0.1%Tempus AIPersonalisfor $16.25 per shareAMC Entertainmentreported better-than-expectedBrookfieldand Canada Pension Plan Investment BoardLXP Industrial Trustin a $5.2B all-cash transactionAlibaba'sAliExpress has been fined EUR550M by the EU for2. WALL STREET CALLS:Phillip SecuritiesNetflix (NFLX) to Buy from AccumulateGoldman SachsTravelersto SellCLSAcoverage of Microsoftwith an Outperform rating and $535 price targetBarclaysLumentumto OverweightPenguin Solutionsto Underweight at Barclays3. AROUND THE WEB:Googleis developing a new AI chip that integrates Gemini model architecture directly into hardware, aiming to improve efficiency and reduce the cost of serving AI models at scale, The Information reportsHoneywellCEO Vimal Kapur said plans to reshape the company were already underway when activist investor Elliott Management took a stake and pushed for a breakup in 2024, Bloomberg saysAppleis piloting a system in Apple Stores called Live Notes that lets Genius Bar staff make transcripts and summaries of conversations with customers, Bloomberg reportsAerCapis in discussions to buy Boeing787 Dreamliner aircraft, with the leasing company considering as many as 15 of the 787 widebodies, Bloomberg saysSamsunghas cut roles at its U.S. display, phone, and consumer electronics operations at its New Jersey and Texas offices, Reuters reports4. MOVERS:Irenhigher after raising its AI Cloud annualizedto over $4B from $3.7BHut 8increases after announcingArcher Aviationgains after announcing its jointly-developedwith AndurilImmix Biopharmalower afterof Chief Medical Officer Richard GraydonEnphase Energy (ENPH) falls after TD Cowenon the stock5. EARNINGS/GUIDANCE:Dynex Capitalwith EPS beating consensusZurn Elkay WaterCEO Todd Adams said the company sees Q2 results "range we provided earlier in the quarter"Nomad FoodsreportedPeoples Bancorp, with EPS higher year-over-yearKnightscope, with revenue higher year-over-yearINDEXES:Near midday, the Dow was down 0.16%, or 83.29, to 52,063.13, the Nasdaq was up 0.80%, or 203.51, to 25,723.75, and the S&P 500 was up 0.42%, or 31.18, to 7,488.87.
Immix Biopharma Terminates Richard Graydon
In a regulatory filing, Immix Biopharma announced that as of July 17, Richard Graydon has been terminated and is no longer with the company for reasons unrelated to his activities at the company. Given his short tenure, management believes there is no material effect on the business.
Immix Biopharma NEXICART-2 Achieves 95% Complete Response Rate
Immix Biopharma announced that all four relapsed/refractory AL Amyloidosis MRD-negative patients presented at ASH 2025 have converted to complete response - CR -. The NEXICART-2 CR rate is now 95% - 19 out of 20 patients -. All CRs were reached within 1 year of follow-up post-dosing. No relapses have been observed as of today for patients who have reached CR. All subsequently enrolled patients for whom MRD results are available are MRD-negative at one month. The next NEXICART-2 update is expected late September. These results support the company's plan to initiate a multi-center, randomized Phase 3 trial in newly diagnosed AL Amyloidosis patients. AL amyloidosis is a devastating disease where the immune system continuously produces toxic light chains, clogging up the heart, kidney and liver, causing organ failure and death. NXC-201 has been awarded Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy by the FDA, and Orphan Drug Designation by the FDA and in the EU by the EMA.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.







